Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
A Phase 2 6-Week, Double-Blind, Placebo-Controlled, Multicenter Trial Of Varenicline Tartrate (CP-526,555) For Cognitive Impairment In Subjects With Schizophrenia
This study was withdrawn before enrollment.
Location not clearly listedClinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedA Multi-center, Open-label Clinical Pharmacology Trial to Investigate the Pharmacokinetics, Tolerability, and Safety of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In TokyoΑ Randomized, Two-way, Two-treatment, Two-period, Crossover, Open Label, Laboratory-blind, Comparative Bioavailability Study at Steady State Between Paliperidone 100 mg Prolonged Release Suspension for Injection (Test Product) and Xeplion® 100 mg Prolonged Release Suspension for Injection (Reference Product) Following Multiple Intramuscular Injections (Five Doses in Each Period, One Dose Every 28 Days) Administration to Patients With Schizophrenia Who Are Already Receiving a Stable Regimen of Paliperidone Prolonged Release Suspension Via The Intramuscular Route
This study has finished and is no longer accepting participants.
Multiple locations, including AmmanA Randomized, Double-blind, Double-dummy, Parallel-group and Multicenter Study to Investigate Lurasidone in Treatment of Schizophrenia Compared With Risperidone
This study has finished and is no longer accepting participants.
Multiple locations, including BeijingResearchers compared Paliperidone palmitate (R092670) and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BaodingResearchers compared LY2140023, Risperidone and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including EscondidoThis study has finished and is no longer accepting participants.
Multiple locations, including BirminghamResearchers compared Lurasidone 20 mg, Lurasidone 40mg, Lurasidone 80 mg, Haloperidol 10mg and placebo, tracking side effects to assess safety in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamRisperidone Depot (Microspheres) vs. Risperidone Tablets - a Non-inferiority, Efficacy Trial in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedComparative Single-Dose Pharmacokinetics and Safety of Gluteal and Deltoid Intramuscular Injection of Long-Acting Injectable Risperidone in Subjects With Chronic Stable Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listed
This study is no longer accepting new participants.
In TaipeiWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.